Mark A. Scheideler

1.6k total citations
41 papers, 1.3k citations indexed

About

Mark A. Scheideler is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Mark A. Scheideler has authored 41 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 28 papers in Cellular and Molecular Neuroscience and 6 papers in Physiology. Recurrent topics in Mark A. Scheideler's work include Receptor Mechanisms and Signaling (23 papers), Neuropeptides and Animal Physiology (11 papers) and Neuroscience and Neuropharmacology Research (10 papers). Mark A. Scheideler is often cited by papers focused on Receptor Mechanisms and Signaling (23 papers), Neuropeptides and Animal Physiology (11 papers) and Neuroscience and Neuropharmacology Research (10 papers). Mark A. Scheideler collaborates with scholars based in United States, Denmark and Italy. Mark A. Scheideler's co-authors include Martine Garnier, Paola Zaratin, Robert M. Bell, Glyn Dawson, Giuseppe Petrone, M. Sbacchi, Kendall Blumer, Paola Petrillo, Brian F. O’Dowd and Helen C. Jackson and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Brain Research.

In The Last Decade

Mark A. Scheideler

41 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark A. Scheideler United States	20	850	814	212	86	82	41	1.3k
Juan M. Luque Spain	22	557 0.7×	727 0.9×	228 1.1×	57 0.7×	58 0.7×	41	1.6k
Dorte Strøbæk Denmark	27	1.9k 2.2×	1.2k 1.5×	307 1.4×	74 0.9×	79 1.0×	40	2.4k
Balázs Szőke United States	19	631 0.7×	421 0.5×	223 1.1×	105 1.2×	94 1.1×	48	1.4k
Keith S. Elmslie United States	28	1.6k 1.9×	1.0k 1.3×	181 0.9×	41 0.5×	52 0.6×	56	1.9k
Rita Raddatz United States	18	1.0k 1.2×	885 1.1×	179 0.8×	186 2.2×	142 1.7×	42	1.7k
Joanne R. Mathiasen United States	19	643 0.8×	443 0.5×	231 1.1×	155 1.8×	93 1.1×	51	1.2k
Michael J. Neal United Kingdom	21	898 1.1×	740 0.9×	147 0.7×	26 0.3×	49 0.6×	46	1.5k
Y. Torrens France	31	1.6k 1.9×	1.8k 2.3×	320 1.5×	83 1.0×	91 1.1×	65	2.2k
Miroslav Cik Belgium	20	889 1.0×	820 1.0×	148 0.7×	40 0.5×	25 0.3×	29	1.4k
B. Dvorkin United States	22	659 0.8×	723 0.9×	260 1.2×	33 0.4×	98 1.2×	31	1.3k

Countries citing papers authored by Mark A. Scheideler

Since Specialization

Citations

This map shows the geographic impact of Mark A. Scheideler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Scheideler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Scheideler more than expected).

Fields of papers citing papers by Mark A. Scheideler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Scheideler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Scheideler. The network helps show where Mark A. Scheideler may publish in the future.

Co-authorship network of co-authors of Mark A. Scheideler

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Scheideler. A scholar is included among the top collaborators of Mark A. Scheideler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Scheideler. Mark A. Scheideler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wolfe, Alan R., R. Jeffrey Neitz, Mark A. Burlingame, et al.. (2018). TPT sulfonate, a single, oral dose schistosomicidal prodrug: In vivo efficacy, disposition and metabolic profiling. International Journal for Parasitology Drugs and Drug Resistance. 8(3). 571–586. 7 indexed citations

J, Li, et al.. (2018). Myelinated axons fail to develop properly in a genetically authentic mouse model of Charcot-Marie-Tooth disease type 2E. Experimental Neurology. 308. 13–25. 31 indexed citations

Zaratin, Paola, Giuseppe Petrone, M. Sbacchi, et al.. (2004). Modification of Nociception and Morphine Tolerance by the Selective Opiate Receptor-Like Orphan Receptor Antagonist (–)-cis-1-Methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5 H-benzocyclohepten-5-ol (SB-612111). Journal of Pharmacology and Experimental Therapeutics. 308(2). 454–461. 131 indexed citations

Zaratin, Paola, Angelo Quattrini, Stefano C. Previtali, et al.. (2004). Schwann cell overexpression of the GPR7 receptor in inflammatory and painful neuropathies. Molecular and Cellular Neuroscience. 28(1). 55–63. 18 indexed citations

Piaz, Vittorio Dal, Claudia Vergelli, Maria Paola Giovannoni, et al.. (2003). 4-Amino-3(2H)-pyridazinones bearing arylpiperazinylalkyl groups and related compounds: synthesis and antinociceptive activity. Il Farmaco. 58(11). 1063–1071. 33 indexed citations

Petrillo, Paola, Sharon Bingham, Martine Garnier, et al.. (2003). Evidence for a Selective Role of the δ-Opioid Agonist [8 R-(4b S*,8aα,8aβ,12bβ)]7,10-Dimethyl-1-methoxy-11-(2-methylpropyl)oxycarbonyl 5,6,7,8,12,12b-hexahydro-(9 H)-4,8-methanobenzofuro[3,2-e]pyrrolo[2,3-g]isoquinoline Hydrochloride (SB-235863) in Blocking Hyperalgesia Associated with Inflammatory and Neuropathic Pain Responses. Journal of Pharmacology and Experimental Therapeutics. 307(3). 1079–1089. 76 indexed citations

Garnier, Martine, Paola Zaratin, Maurizio Valente, et al.. (2003). Up-Regulation of Regulator of G Protein Signaling 4 Expression in a Model of Neuropathic Pain and Insensitivity to Morphine. Journal of Pharmacology and Experimental Therapeutics. 304(3). 1299–1306. 59 indexed citations

Moroni, Flavio, Sabina Attucci, Andrea Cozzi, et al.. (2002). The novel and systemically active metabotropic glutamate 1 (mGlu1) receptor antagonist 3-MATIDA reduces post-ischemic neuronal death. Neuropharmacology. 42(6). 741–751. 49 indexed citations

Collina, Simona, Laura Linati, Maurizio Anzini, et al.. (2001). Enantiomers of 2‐[(Acylamino)ethyl]‐1,4‐benzodiazepines, Potent ligands of κ‐opioid receptor: Chiral chromatographic resolution, configurational assignment, and biological activity. Chirality. 13(9). 606–612. 8 indexed citations

10.

Crider, A. Michael & Mark A. Scheideler. (2001). Recent Advances in the Development of Dopamine D3 Receptor Agonists and Antagonists. Mini-Reviews in Medicinal Chemistry. 1(1). 89–99. 13 indexed citations

11.

Collina, Simona, Ornella Azzolina, M. Sbacchi, et al.. (2000). Synthesis and antinociceptive activity of pyrrolidinylnaphthalenes. Bioorganic & Medicinal Chemistry. 8(8). 1925–1930. 10 indexed citations

12.

Fink‐Jensen, Anders, Erik B. Nielsen, Liselotte Hansen, & Mark A. Scheideler. (1998). Behavioral and neurochemical effects of the preferential dopamine D3 receptor agonist cis-8-OH-PBZI. European Journal of Pharmacology. 342(2-3). 153–161. 17 indexed citations

13.

Scheideler, Mark A., Joel Martin, Rolf Hohlweg, et al.. (1997). The preferential dopamine D3 receptor agonist cis-8-OH-PBZI induces limbic Fos expression in rat brain. European Journal of Pharmacology. 339(2-3). 261–270. 22 indexed citations

14.

Jackson, Helen C. & Mark A. Scheideler. (1996). Behavioural and anticonvulsant effects of Ca2+ channel toxins in DBA/2 mice. Psychopharmacology. 126(1). 85–90. 35 indexed citations

15.

O’Dowd, Brian F., Mark A. Scheideler, Tuan Nguyen, et al.. (1995). The Cloning and Chromosomal Mapping of Two Novel Human Opioid-Somatostatin-like Receptor Genes, GPR7 and GPR8, Expressed in Discrete Areas of the Brain. Genomics. 28(1). 84–91. 103 indexed citations

16.

Jensen, Anders A., et al.. (1994). Characteristics of stably expressed human dopamine D1a and D1b receptors: Atypical behavior of the dopamine D1b receptor. European Journal of Pharmacology Molecular Pharmacology. 267(1). 85–93. 24 indexed citations

17.

Fan, Shufeng, Kai Shen, Mark A. Scheideler, & Stanley M. Crain. (1992). F11 neuroblastoma × DRG neuron hybrid cells express inhibitory μ- and δ-opioid receptors which increase voltage-dependent K+ currents upon activation. Brain Research. 590(1-2). 329–333. 45 indexed citations

18.

Haring, Rachel, Domenico E. Pellegrini‐Giampietro, Stephen R. Zukin, R. Suzanne Zukin, & Mark A. Scheideler. (1991). High Efficiency Reconstitution of a Phencyclidine/MK-801 Receptor Binding Site Solubilized from Rat Forebrain Membranes. Molecular Pharmacology. 40(5). 666–673. 2 indexed citations

19.

Haring, Rachel, Patric K. Stanton, Mark A. Scheideler, & Joseph R. Moskal. (1991). Glycine‐Like Modulation of N‐Methyl‐d‐Aspartate Receptors by a Monoclonal Antibody That Enhances Long‐Term Potentiation. Journal of Neurochemistry. 57(1). 323–332. 28 indexed citations

20.

Scheideler, Mark A. & R. Suzanne Zukin. (1990). Reconstitution of solubilized delta-opiate receptor binding sites in lipid vesicles.. Journal of Biological Chemistry. 265(25). 15176–15182. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact